Stemcell United Limited Share Price Australian S.E.
Equities
BP8
AU000000SCU9
Biotechnology & Medical Research
Sales 2022 | 14.35M 9.61M 801M | Sales 2023 | 339 226.97 18.92K | Capitalization | 3.85M 2.58M 215M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.01M -167M | Net income 2023 | -4M -2.68M -223M | EV / Sales 2022 | 1.07 x |
Net Debt 2022 | 627K 420K 34.99M | Net cash position 2023 | 511K 342K 28.52M | EV / Sales 2023 | 9,862 x |
P/E ratio 2022 |
-3.98
x | P/E ratio 2023 |
-0.72
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.24% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Leonard
CEO | Chief Executive Officer | 53 | 30/23/30 |
Justyn Stedwell
SEC | Corporate Secretary | - | 11/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21/21/21 | |
Paul Stephenson
CHM | Chairman | 63 | 31/20/31 |
Yan Hua Huang
BRD | Director/Board Member | - | 27/19/27 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |